Community-acquired urinary tract infections: causative agents and their resistance to antimicrobial drugs

Zorana Djordjević; Marko Folić; Slobodan Janković

doi:10.2298/VSP150122218D

Zorana Djordjević Epidemiology Department, Clinical Centrе Kragujevac, Kragujevac, Serbia
Marko Folić Clinical Pharmacology Department, Clinical Centrе Kragujevac, Kragujevac, Serbia; Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia
Slobodan Janković Clinical Pharmacology Department, Clinical Centrе Kragujevac, Kragujevac, Serbia; Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia

DOI: https://doi.org/10.2298/VSP150122218D

Keywords: urinary tract infections, urine, bacteria, drug resistance, microbial, outpatients, serbia, age factors, sex factors,

Abstract

Background/Aim. Urinary tract infections (UTIs) are among the most common infections in outpatients. The aim of this study was to define the causative agents of urinary tract infections and their resistance to antimicrobial drugs in the urban area of central Serbia, as well as to evaluate eventual differences associated with age and gender of the patients. Methods. This retrospective study analysed data taken from routine, consecutively collected urine cultures of outpatients with symptomatic UTIs, collected from the Department of Microbiology, Institute of Public Health in Kragujevac, Serbia, from January 2009 to December 2013. Results. There were 71,905 urine cultures, and 24,713 (34.37%) of them were positive for bacterial pathogens. The most common pathogen was Escherichia coli (E. coli) (56.56%), followed by Klebsiella spp. (16.20%), Proteus spp. (14.68%), Enterococcus spp. (5.29%) and Pseudomonas aeruginosa (3.74%). E. coli and Enterococcus spp. isolation rates were lower in males ≥ 60 years old (23.71% and 4.87%, respectively), while Klebsiella spp. was more prevalent in this group (32.06%). The most common causative agents isolated from 15–29 years old male patients were Enterococcus spp. and Pseudomonas aeruginosa (13.28% each). Among women, the isolation rate of E.coli was high in all age groups (around 70%). Proteus spp. was frequently isolated from females ≤ 14 years old (13.27%), while Klebsiella spp. was the most frequent in the oldest age female group (10.99%). Conclusion. Choice of antibiotics for treatment of UTIs should be governed not only by the local resistance patterns, but also by gender and age of patients.

References

Gonzalez CM, Schaeffer AJ. Treatment of urinary tract infection: What's old, what's new, and what works. World J Urol 1999; 17(6): 372−82.

Litwin MS, Saigal CS. Urologic Diseases in America. US, Washington, DC: Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, U.S. Government Publishing Office; 2012.

Institute of Public Health of Serbia “Dr Milan Jovanovic Ba-tut”. Health Statistical Yearbook of Republic of Serbia 2012. Belgrade: Elit medica; 2012.

Hooton TM. Clinical practice. Uncomplicated urinary tract in-fection. N Engl J Med 2012; 366(11): 1028−37.

Laupland KB, Ross T, Pitout JD, Church DL, Gregson DB. Com-munity-onset urinary tract infections: A population-based as-sessment. Infection. 2007; 35(3): 150−3.

Foxman B. Urinary tract infection syndromes: Occurrence, re-currence, bacteriology, risk factors, and disease burden. Infect Dis Clin North Am 2014; 28(1): 1−13.

Salvatore S, Salvatore S, Cattoni E, Siesto G, Serati M, Sorice P, et al. Urinary tract infections in women. Eur J Obstet Gynecol Re-prod Biol 2011; 156(2): 131−6.

Grabe M, Bjerklund-Johansen TE, Botto H, Çek M, Naber KG, Pickard RS, et al. Guidelines on Urological Infections. Arnhem, The Netherlands: European Association of Urology (EAU); 2013.

Alós JI. Epidemiology and etiology of urinary tract infections in the community. Antimicrobial susceptibility of the main pathogens and clinical significance of resistance. Enferm In-fecc Microbiol Clin 2005; 23(Suppl 4): 3−8.

Mačužić B, Vujić A, Janković S. Antibiotic resistance is the cause of urinary tract infections in children. Med J (Krag) 2013; 47(4): 185−91. (Serbian)

Uzunovic-Kamberovic S. Antibiotic resistance of coliform organ-isms from community-acquired urinary tract infections in Zen-ica-Doboj Canton, Bosnia and Herzegovina. J Antimicrob Chemother 2006; 58(2): 344−8.

Clinical and Laboratory Standard Institute (CLSI). Performance standards for antimicrobial susceptibility testing. Wayne, Penn-sylvania: Clinical and Laboratory Standards Institute; 2010.

Francesco MA, Ravizzola G, Peroni L, Negrini R, Manca N. Urinary tract infections in Brescia, Italy: Etiology of uropathogens and antimicrobial resitance of common uropathogens. Med Sci Monit 2007; 13(6): BR136−44.

Cohen-Nahum K, Saidel-Odes L, Riesenberg K, Schlaeffer F, Borer A. Urinary tract infections caused by multi-drug resistant Proteus mirabilis: Risk factors and clinical outcomes. Infection 2010; 38(1): 41−6.

Rahman F, Chowdhury S, Rahman MM, Ahmed D, Hossain A. An-timicrobial resistance pattern of gram-negative bacteria causing urinary tract infection. S J Phar Sci 2009; 2(1): 44−50.

Kiffer CR, Mendes C, Oplustil CP, Sampaio JL. Antibiotic resistance and trend of urinary pathogens in general outpatients from a major urban city. Int Braz J Urol 2007; 33(1): 42−8; discussion 49.

Tabibian JH, Gornbein J, Heidari A, Dien SL, Lau VH, Chahal P, et al. Uropathogens and host characteristics. J Clin Microbiol 2008; 46(12): 3980−6.

Koeijers JJ, Verbon A, Kessels AG, Bartelds A, Donkers G, Nys S, et al. Urinary tract infection in male general practice patients: uropathogens and antibiotic susceptibility. Urology 2010; 76(2): 336−40.

Nimri L. Community-acquired urinary tract infections in a rural area in Jordan: Predominant uropathogens, and their anti-microbial resistance. Webmed Central Microbiol 2010; 1: 1−10.

Magliano E, Grazioli V, Deflorio L, Leuci AI, Mattina R, Romano P, et al. Gender and age-dependent etiology of community-acquired urinary tract infections. Sci World J 2012; 2012: 349597.

Linhares I, Raposo T, Rodrigues A, Almeida A. Frequency and an-timicrobial resistance patterns of bacteria implicated in com-munity urinary tract infections: A ten-year surveillance study. BMC Infect Dis 2013; 13: 19.

Lo DS, Shieh HH, Ragazzi SL, Koch VH, Martinez MB, Gilio AE. Community-acquired urinary tract infection: Age and gender-dependent etiology. J Bras Nefrol 2013; 35(2): 93−8.

Jaquiery A, Stylianopoulos A, Hogg G, Grover S. Vulvovaginitis: Clinical features, aetiology, and microbiology of the genital tract. Arch Dis Child 1999; 81(1): 64−7.

Carlet J, Collignon P, Goldmann D, Goossens H, Gyssens IC, Harbarth S, Voss A. Society's failure to protect a precious resource: Antibiotics. Lancet 2011; 378(9788): 369−71.

Mazzulli T. Resistance trends in urinary tract pathogens and impact on management. J Urol 2002; 168(4 Pt 2): 1720−2.

European Association of Urology (EAU). UT – lower urinary tract infections in females. Uppsala, Sweden: The Medical Products Agency; 2007.

Guneysel O, Onur O, Erdede M, Denizbasi A. Trime-thoprim/sulfamethoxazole resistance in urinary tract infec-tions. J Emerg Med 2009; 36(4): 338−41.

Farrell DJ, Morrissey I, De RD, Robbins M, Felmingham D. A UK multicentre study of the antimicrobial susceptibility of bacterial pathogens causing urinary tract infection. J Infect 2003; 46(2): 94−100.

Kahlmeter G, Poulsen HO. Antimicrobial susceptibility of Esche-richia coli from community-acquired urinary tract infections in Europe: The ECO•SENS study revisited. Int J Antimicrob Agents 2012; 39(1): 45−51.

Bean DC, Krahe D, Wareham DW. Antimicrobial resistance in community and nosocomial Escherichia coli urinary tract iso-lates, London 2005-2006. Ann Clin Microbiol Antimicrob 2008; 7: 13.

Gyssens IC. Antibiotic policy. Int J Antimicrob Agents 2011; 38(Suppl): 11−20.

Schito GC, Naber KG, Botto H, Palou J, Mazzei T, Gualco L, et al. The ARESC study: An international survey on the antimicro-bial resistance of pathogens involved in uncomplicated urinary tract infections. Int J Antimicrob Agents 2009; 34(5): 407−13.